Press Releases Items Per Page 102550 Year None20192018201720162015201420132012201120102007 05.17.18 Syndax Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab) 05.08.18 Syndax Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Clinical and Business Update 05.01.18 Syndax to Announce First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 8, 2018 04.25.18 Syndax Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology Annual Meeting 04.13.18 Syndax to Present at the 2018 American Association for Cancer Research Annual Meeting 03.05.18 Syndax Pharmaceuticals Reports Fourth Quarter 2017 Financial Results and Provides Clinical and Business Update 03.05.18 Syndax Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences 02.26.18 Syndax to Announce Fourth Quarter and Year-end 2017 Financial Results and Host Conference Call and Webcast on March 5, 2018 02.22.18 Syndax Announces Presentations at the 2018 American Association for Cancer Research Annual Meeting 02.01.18 Syndax Announces Immuno-Oncology Clinical Trial Collaboration with AstraZeneca 01.10.18 Syndax Pharmaceuticals Announces Clinical Collaboration to Evaluate Entinostat in Combination with anti-PD-L1 Cancer Immunotherapy in Breast Cancer 11.11.17 Syndax Pharmaceuticals Announces Presentation of Data from Immuno-oncology Clinical Trials at the Society for Immunotherapy of Cancer 32nd Annual Scientific Meeting Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
05.17.18 Syndax Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab)
05.08.18 Syndax Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Clinical and Business Update
05.01.18 Syndax to Announce First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 8, 2018
04.25.18 Syndax Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology Annual Meeting
03.05.18 Syndax Pharmaceuticals Reports Fourth Quarter 2017 Financial Results and Provides Clinical and Business Update
02.26.18 Syndax to Announce Fourth Quarter and Year-end 2017 Financial Results and Host Conference Call and Webcast on March 5, 2018
02.22.18 Syndax Announces Presentations at the 2018 American Association for Cancer Research Annual Meeting
01.10.18 Syndax Pharmaceuticals Announces Clinical Collaboration to Evaluate Entinostat in Combination with anti-PD-L1 Cancer Immunotherapy in Breast Cancer
11.11.17 Syndax Pharmaceuticals Announces Presentation of Data from Immuno-oncology Clinical Trials at the Society for Immunotherapy of Cancer 32nd Annual Scientific Meeting
